JPH107552A5 - - Google Patents

Info

Publication number
JPH107552A5
JPH107552A5 JP1997060781A JP6078197A JPH107552A5 JP H107552 A5 JPH107552 A5 JP H107552A5 JP 1997060781 A JP1997060781 A JP 1997060781A JP 6078197 A JP6078197 A JP 6078197A JP H107552 A5 JPH107552 A5 JP H107552A5
Authority
JP
Japan
Prior art keywords
weight
sustained
release formulation
venlafaxine hydrochloride
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1997060781A
Other languages
English (en)
Japanese (ja)
Other versions
JP4771565B2 (ja
JPH107552A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JPH107552A publication Critical patent/JPH107552A/ja
Publication of JPH107552A5 publication Critical patent/JPH107552A5/ja
Application granted granted Critical
Publication of JP4771565B2 publication Critical patent/JP4771565B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP06078197A 1996-03-25 1997-03-14 持続放出性製剤 Expired - Fee Related JP4771565B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1400696P 1996-03-25 1996-03-25
US60/014006 1996-03-25

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008064149A Division JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Publications (3)

Publication Number Publication Date
JPH107552A JPH107552A (ja) 1998-01-13
JPH107552A5 true JPH107552A5 (show.php) 2004-12-24
JP4771565B2 JP4771565B2 (ja) 2011-09-14

Family

ID=21762972

Family Applications (2)

Application Number Title Priority Date Filing Date
JP06078197A Expired - Fee Related JP4771565B2 (ja) 1996-03-25 1997-03-14 持続放出性製剤
JP2008064149A Pending JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008064149A Pending JP2008156374A (ja) 1996-03-25 2008-03-13 持続放出性製剤

Country Status (33)

Country Link
EP (2) EP0797991B1 (show.php)
JP (2) JP4771565B2 (show.php)
KR (1) KR101096512B1 (show.php)
CN (2) CN1090018C (show.php)
AR (1) AR006519A1 (show.php)
AT (1) ATE257011T1 (show.php)
AU (1) AU727653B2 (show.php)
BR (1) BR9701304A (show.php)
CA (1) CA2199778C (show.php)
CO (1) CO4761054A1 (show.php)
CY (1) CY2442B1 (show.php)
CZ (1) CZ291637B6 (show.php)
DE (1) DE69727000T2 (show.php)
DK (1) DK0797991T3 (show.php)
EG (1) EG24198A (show.php)
ES (1) ES2210454T3 (show.php)
HU (1) HU224617B1 (show.php)
IL (1) IL120382A (show.php)
IN (1) IN187337B (show.php)
NO (2) NO320355B1 (show.php)
NZ (1) NZ314442A (show.php)
PA (1) PA8426401A1 (show.php)
PE (1) PE57198A1 (show.php)
PL (2) PL195564B1 (show.php)
PT (1) PT797991E (show.php)
RU (1) RU2176912C2 (show.php)
SK (1) SK281530B6 (show.php)
SV (1) SV1997000015A (show.php)
TR (1) TR199700190A2 (show.php)
TW (1) TW493993B (show.php)
UA (1) UA44904C2 (show.php)
UY (1) UY24613A1 (show.php)
ZA (1) ZA972403B (show.php)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6274171B1 (en) 1996-03-25 2001-08-14 American Home Products Corporation Extended release formulation of venlafaxine hydrochloride
UA77145C2 (en) * 1997-11-05 2006-11-15 Wyeth Corp Extended release dosage formulation
JP3379461B2 (ja) * 1998-08-06 2003-02-24 三菱電機株式会社 コア部材の積層金型装置、コア部材の積層方法および電動機
IE990406A1 (en) 1999-05-20 2000-12-27 Elan Corp Plc Multiparticulate controlled release selective serotonin reuptake inhibitor formulations.
JP2003500348A (ja) * 1999-05-20 2003-01-07 エラン コーポレーシヨン ピーエルシー 多粒子状制御放出選択的セロトニン再吸収阻害剤製剤
ES2162746B1 (es) * 1999-10-21 2003-02-16 Lipotec Sa Microcapsulas para la estabilizacion de productos cosmeticos, farmaceuticos o de alimentacion.
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US6482440B2 (en) * 2000-09-21 2002-11-19 Phase 2 Discovery, Inc. Long acting antidepressant microparticles
GB0025208D0 (en) * 2000-10-13 2000-11-29 Euro Celtique Sa Delayed release pharmaceutical formulations
JP2004530638A (ja) * 2000-10-19 2004-10-07 テバ ファーマシューティカル インダストリーズ リミティド 結晶性ベンラファクシン塩基、及び新規なベンラファクシン塩酸塩多型形状、ならびにその調製方法
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
AR039164A1 (es) * 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
US20030190351A1 (en) * 2002-03-28 2003-10-09 Synthon Bv Extended release venlafaxine formulations
AR039163A1 (es) 2002-03-28 2005-02-09 Synthon Bv Besilato de venlafaxina
EP1596837A2 (en) * 2003-02-07 2005-11-23 Omega Farma Ehf Sustained release formulations of venlafaxine
TW200503670A (en) * 2003-03-28 2005-02-01 Sandoz Ag Venlafaxine compositions
ES2277030T3 (es) * 2003-05-02 2007-07-01 Dexcel Ltd. Formulacion en comprimidos de venlafaxina de liberacion prolongada.
IN2003MU00504A (show.php) * 2003-06-05 2005-05-13 Alembic Ltd
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
PT1502587E (pt) 2003-07-30 2007-01-31 Pharmathen Sa Formulação de libertação prolongada para cloridrato de venlafaxina
WO2005048979A2 (en) * 2003-10-06 2005-06-02 Torrent Pharmaceuticals Limited Pharmaceutical composition having casing with multiple micro tablets
HUP0303382A2 (hu) * 2003-10-10 2005-08-29 EGIS Gyógyszergyár Rt. Venlafaxin-hidroklorid-tartalmú pelletek
EP1523979A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release pharmaceutical dosage form
EP1523981A1 (en) * 2003-10-13 2005-04-20 Wyeth Extended release formulations of venlafaxine
DE10359154A1 (de) 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
RU2340331C2 (ru) 2004-02-04 2008-12-10 Алембик Лимитед Форма пролонгированного высвобождения венлафаксина гидрохлорида
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US7776358B2 (en) 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
CN100463676C (zh) * 2004-11-11 2009-02-25 成都康弘药业集团股份有限公司 一种盐酸文拉法辛控释片制剂及其制备方法
ITFI20050206A1 (it) * 2005-09-30 2007-04-01 Valpharma Sa Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
CN101453993A (zh) * 2006-04-03 2009-06-10 伊萨·奥迪迪 含有机溶胶涂层的受控释放递送物件
EP2010158B1 (en) 2006-04-26 2016-02-17 Alphapharm Pty Ltd. Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
KR100791194B1 (ko) * 2006-06-12 2008-01-02 코오롱제약주식회사 염산 벤라팍신의 경구 투여용 서방성 펠렛 및 그 제조방법
HUE044221T2 (hu) * 2010-02-03 2019-10-28 Pharma Two B Ltd Nyújtott hatóanyagleadású razagilin készítmények és alkalmazásaik
WO2011132008A2 (en) 2010-04-22 2011-10-27 EGIS Gyűgyszergyár Nyilvánosan Múködő Részvény társaság Controlled release pharmaceutical composition
CA2826180C (en) 2011-01-31 2020-09-01 Serotech, Llc Dosage regimen, medication dispensing package and uses thereof for the treatment of major depressive disorder
CN103893151B (zh) * 2012-12-31 2018-04-27 石药集团中奇制药技术（石家庄）有限公司 一种盐酸文拉法辛缓释胶囊及其制备方法
US12042566B2 (en) 2017-05-17 2024-07-23 Confluence Pharmaceuticals, Llc Formulations of homotaurines and salts thereof
CN114288273B (zh) * 2022-02-11 2022-10-18 桂林华信制药有限公司 一种盐酸文拉法辛缓释胶囊及其生产工艺
JP2023127913A (ja) * 2022-03-02 2023-09-14 共和薬品工業株式会社 ベンラファキシン塩酸塩含有顆粒
JP2025120141A (ja) 2024-02-03 2025-08-15 共和薬品工業株式会社 ベンラファキシン塩酸塩含有徐放性顆粒の製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
IE56324B1 (en) * 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor
US4535186A (en) 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4761501A (en) * 1983-10-26 1988-08-02 American Home Products Corporation Substituted phenylacetamides
IE60311B1 (en) 1987-09-24 1994-06-29 American Home Prod Sustained release etodolac
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
SG47711A1 (en) * 1993-06-28 1998-04-17 American Home Prod New treatments using phenehylamine derivatives
TW344661B (en) * 1993-11-24 1998-11-11 Lilly Co Eli Pharmaceutical composition for treatment of incontinence
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada

Similar Documents

Publication Publication Date Title
JPH107552A5 (show.php)
JP2007511510A (ja) 持続放出性ベンラファキシン製剤
KR970064599A (ko) 서방성 제형
CA2038245C (en) Pharmaceutically useful micropellets
JP4369752B2 (ja) プロプラノロールの時限徐放性多粒子剤型
AU2005247019B2 (en) Multiparticulate modified release composition
EP1465608B1 (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
RU97103563A (ru) Композиции длительного высвобождения венлафаксин гидрохлорида, композиция пленочного покрытия, способ обеспечения терапевтически активной концентрации венлафаксина и способ исключения нулевых и пиковых концентраций лекарственного средства
IE59200B1 (en) Therapeutic compositions for oral administration
US20030185887A1 (en) Controlled release oral dosage form of beta-adrenergic blocking agents
NZ200519A (en) Sustained release pellet containing indoramin
JPH04217918A (ja) 一日一回投与のための吸収の制御されたナプロキセン配合物
SK6252001A3 (en) New controlled release bead, a method of producing the same and multiple unit formulation comprising it
MY148475A (en) Controlled release preparations comprising tramadol and topiramate
US10213389B2 (en) Controlled release compositions comprising a combination of isosorbide dinitrate and hydralazine hydrochloride
JPH0662405B2 (ja) Ｌ―ドーパ含有組成物
WO2006063078A2 (en) Topiramate pharmaceuticals composition
CA2453263A1 (en) Pharmaceutical compositions containing terbinafine and use thereof
AU2005279329A1 (en) Pharmaceutical multiparticulate compositions comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin
CA2068980A1 (en) Diltiazem formulation
JP2004532828A5 (show.php)
WO1999042087A3 (en) Controlled release potassium chloride pellet based pharmaceutical compositions having a high active ingredient content
CA2433915A1 (en) Improved controlled release oral dosage form
JP2002512946A5 (show.php)
RU99125610A (ru) Твердые фармацевтические препараты, содержащие физическую смесь сульфоалкилового эфира циклодекстрина и терапевтического агента